DI FILIPPO, PAOLA SOFIA

DI FILIPPO, PAOLA SOFIA  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
A multimodal approach to distinguish multiple sclerosis phenotypes at diagnosis using biomarker profiles 1-gen-2025 Zanghi', A; Di Filippo, Paola Sofia; Greco, A; Rutigliano, C; Giancipoli, E; Iaculli, C; Avolio, C; D'Amico, E
Cognitive and structural brain changes in ofatumumab-treated multiple sclerosis: A longitudinal study 1-gen-2026 Zanghi', A; Di Filippo, Paola Sofia; Robusto, C; Moretti, Mc; Avolio, C; D'Amico, E.
Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab 1-gen-2025 Zanghi', A; Di Filippo, Paola Sofia; Rutigliano, C; Avolio, C; D'Amico, E.
Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV IgG Tests in RRMS to Assess PML Risk 1-gen-2025 Zanghi', A; Marinelli, F; Di Filippo, Paola Sofia; Avolio, C; D'Amico, E
Cortical Atrophy and Cognitive Outcomes in Relapsing MS Patients Treated With Ofatumumab: a Real-World Longitudinal Study 1-gen-2026 Zanghi', A; Di Filippo, Paola Sofia; Rutigliano, C; Avolio, C; D'Amico, E
Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMS 1-gen-2025 Zanghi', A; DI FILIPPO, PAOLA SOFIA; Avolio, C; D'Amico, E.
Making the invisible audible: a real-world connected speech study in myasthenia gravis 1-gen-2026 Zanghi', A; Di Filippo, Paola Sofia; Rutigliano, C; Avolio, C; D'Amico, E
Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study 1-gen-2025 Zanghi', A; Di Filippo, Paola Sofia; Papale, M; Rutigliano, C; Moretti, Mc; Avolio, C; Corso, G; D'Amico, E.
Multidomain Fatigue, Cognitive, and Quality of Life Observations in Generalized Myasthenia Gravis Under Ravulizumab: A Case Series 1-gen-2026 Zanghi', A; Di Filippo, Paola Sofia; Rutigliano, C; Avolio, C; D'Amico, E
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice 1-gen-2026 Zanghi', A; Borriello, G; Foschi, M; Bianco, A; Signoriello, E; Cellerino, M; Di Filippo, Paola Sofia; Baldisseri, F; Romano, G; Cicia, A; Lus, G; Inglese, M; Mirabella, M; Avolio, C; D'Amico, E
Transitioning from intravenous to subcutaneous ocrelizumab in a high-volume infusion center: A time-and-motion-informed capacity and service-flow analysis 1-gen-2026 Zanghi', A; Di Filippo, Paola Sofia; Robusto, C; Moretti, Mc; Avolio, C; D'Amico, E